Danish drugmaker Novo Nordisk has reduced the price of its popular weight-loss drug, Wegovy, by up to 37% from its launch price in India. This move is aimed at increasing its market share in the fast-growing Indian market for obesity treatments. The company's document sent to distributors shows the price...